Michael Partridge | SVP, IR |
Charles Wagner | EVP and CFO |
Jeff Leiden | Chairman, CEO, and President |
Reshma Kewalramani | EVP, Global Medicines Development and Medical Affairs and CMO |
Stuart Arbuckle | EVP and CCO |
Phil Nadeau | Cowen & Company |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Alethia Young | Cantor Fitzgerald |
Cory Kasimov | JPMorgan |
Matthew Harrison | Morgan Stanley |
Brian Abrahams | RBC Capital Markets |
Paul Matteis | Stifel |
Geoffrey Porges | SVB Leerink |
Mohit Bansal | Citi |
Brian Skorney | Baird |
Whitney Ijem | Guggenheim |
Evan Seigerman | Credit Suisse |
Welcome. This is Michael Partridge, Senior Vice President of Investor Relations. Tonight, we will review with you Vertex's Business Progress and provide our Second Quarter Financial Results.
Making prepared remarks on the call tonight, we have Dr. Jeff Leiden, Chairman and CEO; Dr.